$LYB

LyondellBasell price target lowered to $41 from $43 at UBS

UBS reduced its price target on LyondellBasell (LYB) to $41 from $43, maintaining a Sell rating. The firm cited weak markets in its research note.

Original reporting
Published Sep 16, 2026, 1:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LyondellBasell price target lowered to $41 from $43 at UBS — source image
Decision brief

The 30-second read

$LYBBearishLow
01

Why it matters

The downgrade may trigger sell pressure, but the modest target change suggests limited immediate volatility.

02

Market read

Analyst target cut is a modest negative catalyst for LYB, with limited broader market effect.

03

What to watch

Potential upcoming contract wins or cost‑saving initiatives not reflected in the target.

Relevance 6/10Novelty 5/10Timing: today

Background

UBS analysts focus on cash generation and note weak market conditions for LYB.

Company-level read

Ticker impact

$LYBBearishMedium confidence
Context

UBS lowered LYB's price target to $41 from $43 and maintained a Sell rating.

Expected impact

Potential short-term downside as investors adjust expectations.

Evidence & confidence

Target reduction signals weaker outlook; no new corporate event, only analyst opinion.

Market effects

Chemicals sector may see slight pressure as a major player receives a lower target.

US market sentiment toward petrochemical stocks could soften.

Limited; impact confined to LYB and peers.

Counterpoint

Investors may view the target cut as an overreaction and look for buying opportunities.

Key entities

  • LyondellBasell

    Global chemicals producer (ticker LYB).

  • UBS

    Investment bank providing the price target revision.

Related articles

$SHELMedAI 8/10

Business Watch: DOE gives out money for batteries; Genentech licenses a GLP-1 alternative

Shell is receiving bids for its US petrochemical business, potentially worth $8 billion, from rivals like LyondellBasell and ExxonMobil, as well as private equity firms. The sale may include Shell's ethylene and polyethylene complex in Pennsylvania and other sites. LyondellBasell has a history of acquiring new plants at lower prices, while ExxonMobil is already in related businesses. Kuwait Petroleum may be interested in Shell's ethylene oxide derivatives.

$XOMHighAI 9/10

Exxon and LyondellBasell Eye Shell’s US Chemicals Portfolio – FT

Exxon Mobil (XOM) and LyondellBasell (LYB) are among potential bidders for Shell's (SHEL) US chemicals assets, valued at up to $8B. Other interested parties include Apollo and Kuwait Petroleum Corporation. The portfolio includes four facilities, with Shell seeking to divest weaker-performing operations. Shell is also reviewing European chemicals assets for potential sales.